The phospholipid market size has grown strongly in recent years. It will grow from $3.62 billion in 2024 to $3.86 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising demand for natural ingredients, pharmaceutical applications, nutraceutical and dietary supplements, cosmetics and personal care, food industry applications.
The phospholipid market size is expected to see strong growth in the next few years. It will grow to $5.22 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to nutraceutical and functional foods, clean label trend, cosmetics and personal care innovations, biotechnological and industrial applications, research and development investments. Major trends in the forecast period include advanced drug delivery systems, functional foods and supplements, liposomal formulations, research in lipidomics, enhanced cosmetic formulations.
The increasing demand for green and organic food is anticipated to drive the growth of the phospholipid market in the future. Green and organic food refers to products cultivated without synthetic chemicals, employing environmentally sustainable practices. The emphasis on green and organic food in phospholipids focuses on sourcing natural, eco-friendly materials to develop healthier and more sustainable phospholipid-based products. For example, in December 2023, the United States Department of Agriculture, a federal agency in the US, reported that India produced 2.9 million metric tons of certified edible organic products for the 2022-23 period. Thus, the rising demand for green and organic food is propelling the growth of the phospholipid market.
The rise in the aging population is expected to contribute significantly to the growth of the phospholipid market. As the proportion of elderly individuals in society increases, phospholipids become essential for maintaining cell membrane structure and function, potentially mitigating age-related cognitive decline. The World Health Organization projected that by 2030, one in six individuals globally would be 60 years or older, with the global population of individuals aged 60 and older expected to double to 2.1 billion by 2050. This demographic shift is a key driver for the phospholipid market.
Product innovation has emerged as a key trend gaining traction in the phospholipid market. Leading companies in the sector are developing cutting-edge products to enhance their market presence. For example, in May 2024, Aker BioMarine, a biotechnology innovator based in Norway, introduced PL+ DHA/EPA delivery technology. This innovative platform leverages natural marine phospholipids to improve the absorption of other ingredients. It enables dual solubility in both water and fats, functioning as an emulsifier and increasing absorption by up to 25 times. The formulation combines krill phospholipids with processed fish oil to create more effective emulsions for the uptake of EPA and DHA in the stomach.
Leading companies in the phospholipid market are focusing on enzyme products, such as microbial phospholipase A2, to provide a microbial alternative. Microbial phospholipase A2 is an enzyme that catalyzes the hydrolysis of the ester bond in phospholipids, resulting in the release of a fatty acid and lysophospholipid. For instance, in March 2023, NZMP, a New Zealand-based company specializing in dairy nutrition, launched Nutiani, a new business-to-business health and wellbeing brand. Nutiani aims to offer innovative nutrition solutions with a focus on ingredients that promote mental, physical, and inner wellbeing. The phospholipids used in Nutiani are sourced from milk fat globule membranes (MFGM), which contain a range of essential phospholipids, including Phosphatidylserine, Phosphatidylcholine, and Sphingomyelin. The brand leverages NZMP’s expertise in dairy and nutritional science to provide tailored products for the health and wellness industry.
In July 2023, Croda International Plc acquired Solus Biotech for an undisclosed amount. This acquisition expands Croda's access to Solus’ biotech-derived ceramide and phospholipid technologies, along with emerging capabilities in natural retinol. Solus Biotech, based in South Korea, produces phospholipids at a GMP plant, offering applications as delivery systems for pharmaceutical actives and cosmetics.
Major companies operating in the phospholipid market include The Archer-Daniels-Midland Company, Bunge India Private Limited, Cargill Incorporated, Wilmar International Limited, Lasenor Emul SL, Kewpie Corporation, Lipoid GmbH, Sojaprotein, VAV Life Sciences Pvt. Ltd., Avanti Polar Lipids Inc., Lecico GmbH, Sime Darby Oils Zwijndrecht Refinery B.V., Stern-Wywiol Gruppe, Berg + Schmidt India Pvt. Ltd., Novastell India Private Limited, American Lecithin Company, Austrade, Barentz International BV, Beijing Gingko-Group Biological Technology Co. Ltd, Bergstrom Nutrition Inc., BioActor BV, Bioiberica S.A.U., Caelus Health B.V., Chemi S.p.A., Croda International Plc., Denofa AS, Enzymotec Ltd., Royal FrieslandCampina N.V., Gnosis Advanced Biotech, HARKE Chemicals GmbH, Jiusan Oils & Grains Industries Group, Kerry Group plc.
North America was the largest region in the phospholipid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the phospholipid market during the forecast period. The regions covered in the phospholipid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the phospholipid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Phospholipids are lipid compounds composed of fatty acids, alcohol, phosphoric acids, and a nitrogen base. They serve as the primary constituent of the cell membrane, imparting a fluid characteristic to the membranes. Across diverse industries, phospholipids find applications as emulsifiers, wetting agents, solubilizers, and liposome formers.
The principal varieties of phospholipids encompass phosphatidic acid, phosphatidylglycerol, phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine, and phosphoinositides. A phospholipid, or compound fatty acid, denotes phosphatidic acid and is produced through the covalent bonding of two fatty acids with a phosphate group and a glycerol molecule. This compound is utilized as a therapeutic agent for addressing various conditions, including depression, mental stress, medications, and cancer. Derived from sources such as soy and eggs, phospholipids are available in powder and granule forms, applied in diverse sectors such as nutrition and supplements, pharmaceuticals, among others.
The phospholipid market research report is one of a series of new reports that provides phospholipid market statistics, including phospholipid industry global market size, regional shares, competitors with a phospholipid market share, detailed phospholipid market segments, market trends, and opportunities, and any further data you may need to thrive in the phospholipid industry. This phospholipid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The phospholipid market consists of sales of phosphatidylinositol, cardiolipin, and sphingomyelin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The phospholipid market size is expected to see strong growth in the next few years. It will grow to $5.22 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to nutraceutical and functional foods, clean label trend, cosmetics and personal care innovations, biotechnological and industrial applications, research and development investments. Major trends in the forecast period include advanced drug delivery systems, functional foods and supplements, liposomal formulations, research in lipidomics, enhanced cosmetic formulations.
The increasing demand for green and organic food is anticipated to drive the growth of the phospholipid market in the future. Green and organic food refers to products cultivated without synthetic chemicals, employing environmentally sustainable practices. The emphasis on green and organic food in phospholipids focuses on sourcing natural, eco-friendly materials to develop healthier and more sustainable phospholipid-based products. For example, in December 2023, the United States Department of Agriculture, a federal agency in the US, reported that India produced 2.9 million metric tons of certified edible organic products for the 2022-23 period. Thus, the rising demand for green and organic food is propelling the growth of the phospholipid market.
The rise in the aging population is expected to contribute significantly to the growth of the phospholipid market. As the proportion of elderly individuals in society increases, phospholipids become essential for maintaining cell membrane structure and function, potentially mitigating age-related cognitive decline. The World Health Organization projected that by 2030, one in six individuals globally would be 60 years or older, with the global population of individuals aged 60 and older expected to double to 2.1 billion by 2050. This demographic shift is a key driver for the phospholipid market.
Product innovation has emerged as a key trend gaining traction in the phospholipid market. Leading companies in the sector are developing cutting-edge products to enhance their market presence. For example, in May 2024, Aker BioMarine, a biotechnology innovator based in Norway, introduced PL+ DHA/EPA delivery technology. This innovative platform leverages natural marine phospholipids to improve the absorption of other ingredients. It enables dual solubility in both water and fats, functioning as an emulsifier and increasing absorption by up to 25 times. The formulation combines krill phospholipids with processed fish oil to create more effective emulsions for the uptake of EPA and DHA in the stomach.
Leading companies in the phospholipid market are focusing on enzyme products, such as microbial phospholipase A2, to provide a microbial alternative. Microbial phospholipase A2 is an enzyme that catalyzes the hydrolysis of the ester bond in phospholipids, resulting in the release of a fatty acid and lysophospholipid. For instance, in March 2023, NZMP, a New Zealand-based company specializing in dairy nutrition, launched Nutiani, a new business-to-business health and wellbeing brand. Nutiani aims to offer innovative nutrition solutions with a focus on ingredients that promote mental, physical, and inner wellbeing. The phospholipids used in Nutiani are sourced from milk fat globule membranes (MFGM), which contain a range of essential phospholipids, including Phosphatidylserine, Phosphatidylcholine, and Sphingomyelin. The brand leverages NZMP’s expertise in dairy and nutritional science to provide tailored products for the health and wellness industry.
In July 2023, Croda International Plc acquired Solus Biotech for an undisclosed amount. This acquisition expands Croda's access to Solus’ biotech-derived ceramide and phospholipid technologies, along with emerging capabilities in natural retinol. Solus Biotech, based in South Korea, produces phospholipids at a GMP plant, offering applications as delivery systems for pharmaceutical actives and cosmetics.
Major companies operating in the phospholipid market include The Archer-Daniels-Midland Company, Bunge India Private Limited, Cargill Incorporated, Wilmar International Limited, Lasenor Emul SL, Kewpie Corporation, Lipoid GmbH, Sojaprotein, VAV Life Sciences Pvt. Ltd., Avanti Polar Lipids Inc., Lecico GmbH, Sime Darby Oils Zwijndrecht Refinery B.V., Stern-Wywiol Gruppe, Berg + Schmidt India Pvt. Ltd., Novastell India Private Limited, American Lecithin Company, Austrade, Barentz International BV, Beijing Gingko-Group Biological Technology Co. Ltd, Bergstrom Nutrition Inc., BioActor BV, Bioiberica S.A.U., Caelus Health B.V., Chemi S.p.A., Croda International Plc., Denofa AS, Enzymotec Ltd., Royal FrieslandCampina N.V., Gnosis Advanced Biotech, HARKE Chemicals GmbH, Jiusan Oils & Grains Industries Group, Kerry Group plc.
North America was the largest region in the phospholipid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the phospholipid market during the forecast period. The regions covered in the phospholipid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the phospholipid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Phospholipids are lipid compounds composed of fatty acids, alcohol, phosphoric acids, and a nitrogen base. They serve as the primary constituent of the cell membrane, imparting a fluid characteristic to the membranes. Across diverse industries, phospholipids find applications as emulsifiers, wetting agents, solubilizers, and liposome formers.
The principal varieties of phospholipids encompass phosphatidic acid, phosphatidylglycerol, phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine, and phosphoinositides. A phospholipid, or compound fatty acid, denotes phosphatidic acid and is produced through the covalent bonding of two fatty acids with a phosphate group and a glycerol molecule. This compound is utilized as a therapeutic agent for addressing various conditions, including depression, mental stress, medications, and cancer. Derived from sources such as soy and eggs, phospholipids are available in powder and granule forms, applied in diverse sectors such as nutrition and supplements, pharmaceuticals, among others.
The phospholipid market research report is one of a series of new reports that provides phospholipid market statistics, including phospholipid industry global market size, regional shares, competitors with a phospholipid market share, detailed phospholipid market segments, market trends, and opportunities, and any further data you may need to thrive in the phospholipid industry. This phospholipid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The phospholipid market consists of sales of phosphatidylinositol, cardiolipin, and sphingomyelin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Phospholipid Market Characteristics3. Phospholipid Market Trends and Strategies4. Phospholipid Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Phospholipid Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Phospholipid Market34. Recent Developments in the Phospholipid Market
5. Global Phospholipid Growth Analysis and Strategic Analysis Framework
6. Phospholipid Market Segmentation
7. Phospholipid Market Regional and Country Analysis
8. Asia-Pacific Phospholipid Market
9. China Phospholipid Market
10. India Phospholipid Market
11. Japan Phospholipid Market
12. Australia Phospholipid Market
13. Indonesia Phospholipid Market
14. South Korea Phospholipid Market
15. Western Europe Phospholipid Market
16. UK Phospholipid Market
17. Germany Phospholipid Market
18. France Phospholipid Market
19. Italy Phospholipid Market
20. Spain Phospholipid Market
21. Eastern Europe Phospholipid Market
22. Russia Phospholipid Market
23. North America Phospholipid Market
24. USA Phospholipid Market
25. Canada Phospholipid Market
26. South America Phospholipid Market
27. Brazil Phospholipid Market
28. Middle East Phospholipid Market
29. Africa Phospholipid Market
30. Phospholipid Market Competitive Landscape and Company Profiles
31. Phospholipid Market Other Major and Innovative Companies
35. Phospholipid Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Phospholipid Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on phospholipid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for phospholipid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The phospholipid market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Type: Phosphatidic Acid; Phosphatidylglycerol; Phosphatidylethanolamine; Phosphatidylcholine; Phosphatidylserine; Phosphoinositides2) by Source: Soy; Eggs; Other Sources
3) by Form: Powder; Granule
4) by Application: Nutrition and Supplements; Pharmaceuticals; Other Applications
Subsegments:
1) by Phosphatidic Acid: 1,2-Diacyl-sn-glycero-3-phosphate; 1,3-Diacyl-sn-glycero-3-phosphate2) by Phosphatidylglycerol: 1,2-Diacyl-sn-glycero-3-phosphoglycerol; Lysophosphatidylglycerol
3) by Phosphatidylethanolamine: 1,2-Diacyl-sn-glycero-3-phosphoethanolamine; N-acylphosphatidylethanolamine
4) by Phosphatidylcholine: 1,2-Diacyl-sn-glycero-3-phosphocholine; Lysophosphatidylcholine
5) by Phosphatidylserine: 1,2-Diacyl-sn-glycero-3-phospho-L-serine; Lysophosphatidylserine
6) by Phosphoinositides: Phosphatidylinositol; Phosphatidylinositol 4-phosphate; Phosphatidylinositol 4,5-bisphosphate
Key Companies Mentioned: the Archer-Daniels-Midland Company; Bunge India Private Limited; Cargill Incorporated; Wilmar International Limited; Lasenor Emul SL
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Phospholipid market report include:- The Archer-Daniels-Midland Company
- Bunge India Private Limited
- Cargill Incorporated
- Wilmar International Limited
- Lasenor Emul SL
- Kewpie Corporation
- Lipoid GmbH
- Sojaprotein
- VAV Life Sciences Pvt. Ltd.
- Avanti Polar Lipids Inc.
- Lecico GmbH
- Sime Darby Oils Zwijndrecht Refinery B.V.
- Stern-Wywiol Gruppe
- Berg + Schmidt India Pvt. Ltd.
- Novastell India Private Limited
- American Lecithin Company
- Austrade
- Barentz International BV
- Beijing Gingko-Group Biological Technology Co. Ltd
- Bergstrom Nutrition Inc.
- BioActor BV
- Bioiberica S.A.U.
- Caelus Health B.V.
- Chemi S.p.A.
- Croda International Plc.
- Denofa AS
- Enzymotec Ltd.
- Royal FrieslandCampina N.V.
- Gnosis Advanced Biotech
- HARKE Chemicals GmbH
- Jiusan Oils & Grains Industries Group
- Kerry Group plc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 3.86 Billion |
| Forecasted Market Value ( USD | $ 5.22 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
